tradingkey.logo

Quest Diagnostics Long-Term Outlook Beyond 2025 4%-5% Revenue Cagr, 7%-9% Adjusted EPS Cagr

ReutersJan 12, 2026 11:12 PM

- SEC Filing:

  • QUEST DIAGNOSTICS: LONG-TERM OUTLOOK BEYOND 2025: 4%-5% REVENUE CAGR, 7%-9% ADJUSTED EPS CAGR

Source text: [ID:n0000947871-26-000025]

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI